It's Not JUST Idiopathic Pulmonary Fibrosis Study (INJUSTIS)

  • End date
    Nov 11, 2022
  • participants needed
  • sponsor
    University of Nottingham
Updated on 14 February 2022
ct scan
pulmonary disease
pulmonary fibrosis
idiopathic pulmonary fibrosis
interstitial lung disease
lung biopsy


Study of progression of fibrosis in ILD


The overall aims of this study are

  • Identify biomarkers and gene expression profiles that determine progressive fibrotic lung disease regardless of aetiology
  • To prospectively assess biomarkers which predict progressive fibrosis in patients with fibrosing lung disease of alternate aetiology, including RA-UIP, Asbestosis, Chronic Hypersensitivity Pneumonitis and Unclassifiable fibrotic lung disease
  • Investigate genetic associations and epigenetic modifications which affect fibrotic disease severity and progression
  • Prospectively evaluate longitudinal disease behaviour in patients with non IPF-fibrotic lung diseases with a view to developing composite clinical end-points for subsequent use in intervention studies in patients

Condition Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis
Treatment Quality of Life Questionnaires, Optional Bronchoscopy, Blood Samples for Biomarkers, Home Hand Held Spirometry
Clinical Study IdentifierNCT03670576
SponsorUniversity of Nottingham
Last Modified on14 February 2022


Yes No Not Sure

Inclusion Criteria

Male or female aged 18 years old
Able and willing to give written informed consent
Recently diagnosed [defined as diagnostic CT scan or surgical lung biopsy (if applicable) >1st May 2017]
An MDT diagnosis of fibrotic interstitial lung disease (reticulation, traction +/- honeycombing)
Sub Groups
Rheumatoid arthritis (rheumatologist diagnosed with anti-CCP antibodies and/or Rheumatoid Factor positive)
Asbestosis (appropriate occupational history and radiological evidence of asbestos exposure)
Chronic HP in accordance with consensus criteria (appropriate exposure history, radiological features +/- avian and fungal precipitins)
Unclassifiable fibrotic lung disease (fibrotic lung disease otherwise unclassifiable despite extensive clinical and radiological examination)
IPF in accordance with consensus criteria (ATS/ERS/JRS/ALAT guidelines) as controls

Exclusion Criteria

Participating in an interventional clinic trial
Asymptomatic Interstitial Lung Abnormalities (ILA) and normal lung function
Change in clinical phenotype from initial radiological diagnosis to screening
Acute Hypersensitivity Pneumonitis
Participants who do not possess a smartphone or have a valid email address (necessary for the home FVC readings)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note